Literature DB >> 20062752

Ceftriaxone-induced toxic epidermal necrolysis mimicking burn injury: a case report.

Sarit Cohen1, Allan Billig, Dean Ad-El.   

Abstract

INTRODUCTION: Toxic epidermal necrolysis is a rare exfoliative disorder with a high mortality rate. CASE
PRESENTATION: We present a 70-year-old woman of Iranian descent who presented with toxic epidermal necrolysis that was initially diagnosed as a scald burn. Further anamnesis prompted by spread of the lesions during hospitalization revealed that the patient had been receiving ceftriaxone for several days. To the best of our knowledge, this is the first case of ceftriaxone-induced toxic epidermal necrolysis in the English literature.
CONCLUSION: Toxic epidermal necrolysis is an acute, life-threatening, exfoliative disorder with a high mortality rate. High clinical suspicion, prompt recognition, and initiation of supportive care is mandatory. Thorough investigation of the pathogenetic mechanisms is fundamental. Optimal treatment guidelines are still unavailable.

Entities:  

Year:  2009        PMID: 20062752      PMCID: PMC2803846          DOI: 10.1186/1752-1947-3-9323

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  13 in total

1.  T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.

Authors:  H Miyauchi; H Hosokawa; T Akaeda; H Iba; Y Asada
Journal:  Arch Dermatol       Date:  1991-06

Review 2.  Lyell's syndrome.

Authors:  Adone Baroni; Eleonora Ruocco
Journal:  Skinmed       Date:  2005 Jul-Aug

Review 3.  Toxic epidermal necrolysis: a review.

Authors:  R Avakian; F P Flowers; O E Araujo; F A Ramos-Caro
Journal:  J Am Acad Dermatol       Date:  1991-07       Impact factor: 11.527

4.  Cephalexin induced toxic epidermal necrolysis.

Authors:  J Dave; R Heathcock; L Fenelon; D J Bihari; N A Simmons
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

Review 5.  Toxic epidermal necrolysis: current evidence, practical management and future directions.

Authors:  T A Chave; N J Mortimer; M J Sladden; A P Hall; P E Hutchinson
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

6.  Toxic epidermal necrolysis due to cephalexin.

Authors:  D J Hogan; M E Rooney
Journal:  J Am Acad Dermatol       Date:  1987-11       Impact factor: 11.527

7.  Toxic epidermal necrolysis due to cephem.

Authors:  M Okano; Y Kitano; K Ohzono
Journal:  Int J Dermatol       Date:  1988-04       Impact factor: 2.736

8.  The Parkland formula in patients with burns and inhalation injury.

Authors:  J J Scheulen; A M Munster
Journal:  J Trauma       Date:  1982-10

9.  Outcome of patients with toxic epidermal necrolysis syndrome revisited.

Authors:  Ivica Ducic; Avshalom Shalom; William Rising; Ken Nagamoto; Andrew M Munster
Journal:  Plast Reconstr Surg       Date:  2002-09-01       Impact factor: 4.730

10.  Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis.

Authors:  C Paul; P Wolkenstein; H Adle; J Wechsler; H J Garchon; J Revuz; J C Roujeau
Journal:  Br J Dermatol       Date:  1996-04       Impact factor: 9.302

View more
  3 in total

1.  Intravenous immunoglobulin in the treatment of vancomycin-induced toxic epidermal necrolysis.

Authors:  Mohamed A El-Naggari; Hashim Javad; Alexander P Chacko; Anas A Abdelmogheth
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

Review 2.  Drug-hypersensitivity syndrome: diagnosis and treatment.

Authors:  Rose L Hamm
Journal:  J Am Coll Clin Wound Spec       Date:  2012-06-23

3.  Fatal case of cephalexin-induced toxic epidermal necrolysis.

Authors:  Matthew J Hafermann; Gerard R Barber; Stephen C Dreskin; Gordon K Lindberg
Journal:  SAGE Open Med Case Rep       Date:  2014-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.